ClinicalTrials.gov
ClinicalTrials.gov Menu

A Phase I Randomized Placebo-Controlled, Double-Blind Study to Evaluate Safety and Immunogenicity of AERAS‑404 Administered as Different Amounts of Antigen and Adjuvant Combinations in HIV-Negative BCG-Vaccinated Adults Without Evidence of Tuberculosis Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02066428
Recruitment Status : Completed
First Posted : February 19, 2014
Last Update Posted : February 19, 2014
Sponsor:
Collaborator:
Statens Serum Institut
Information provided by (Responsible Party):
Aeras